Professional Documents
Culture Documents
Urinary Tract Infections: MBCHB Vi
Urinary Tract Infections: MBCHB Vi
MBChB VI
Dr. Bernard B. O. Awuonda
http://ecampus.maseno.ac.ke Slide 1 of 5
Topic outline
Introduction
Epidemiology
Classification of UTI
Presentation
Investigations
Management
Complications
http://ecampus.maseno.ac.ke Slide 2 of 5
Introduction
http://ecampus.maseno.ac.ke Slide 3 of 5
Factors which limit multiplication of organisms
High rate of urine flow
Regular complete bladder emptying
Urinary glycosaminoglycans(Tamm-Horsfall
mucoprotein)
Mucosal defences-secretions of IgA and IgG
http://ecampus.maseno.ac.ke Slide 4 of 5
Goals of treatment
The goals of treatment for UTI include :
Elimination of infection and prevention of urosepsis
Prevention of recurrence and long-term complications
including hypertension, renal scarring, and impaired renal
growth and function
Relief of acute symptoms (eg, fever, dysuria, frequency)
http://ecampus.maseno.ac.ke Slide 5 of 5
Urethriris
Definition
◦ Inflammation of the urethra
Etiology
a) Gonococcal urethritis
◦ N.gonorrhea
b) Non gonococcal urethritis
◦ C.Trachomatis
◦ Ureaplasma urealyticum
◦ Trichomonas vaginalis
◦ Herpes simples virus
http://ecampus.maseno.ac.ke Slide 6 of 5
Decision to hospitalise
Most infants older than two months with UTI can be safely managed
as outpatients as long as close follow-up is possible .
http://ecampus.maseno.ac.ke Slide 7 of 5
Gonococcal urethritis
Etiology- N.gonorrhea
Pathogenesis:
◦ The bacteria infects the columnar epithelium of he
urethra but can also infect the rectum, pharynx and
the eye
http://ecampus.maseno.ac.ke Slide 8 of 5
Clinical features
Burning sensation of urine
Urethral discharge in 90-95% of men
60% of women with this infection are
asymptomatic.
In women the symptoms are dysuria and
vaginal discharge
http://ecampus.maseno.ac.ke Slide 9 of 5
Investigations
Urethral swab
◦ gram stain-Gram negative diplococci
Culture
◦ growth of gram negative diplococci
http://ecampus.maseno.ac.ke Slide 10 of 5
Treatment
Antibiotics
Penicillins
Quinolones
http://ecampus.maseno.ac.ke Slide 11 of 5
Complications of gonorrhea
Epididymo-orchitis
Pelvic inflammatory disease
Acute gonococcal arthritis
septiceamia
Ophthalmia neonatorum
http://ecampus.maseno.ac.ke Slide 12 of 5
Prevention
Use of condoms
Treatment of infected partner
http://ecampus.maseno.ac.ke Slide 13 of 5
Non gonococcal urethritis
Etiology
◦ Chlaymidia trachomatis- accounts for 50%
◦ Ureaplasma urealyticum
◦ Trichomonas vaginalis
◦ Herpes simplex virus
http://ecampus.maseno.ac.ke Slide 14 of 5
Clinical presentation
In men:
Features resembles those of gonococcal
urethritis but milder
The causative ogarnism is T.vaginalis
In women:
50% are due to C. trachomatis and
50% -no causes have been identified
http://ecampus.maseno.ac.ke Slide 15 of 5
Investigations
In men:
Urethral swab
wet preparation-T.vaginalis
In women:
Serology-antigen detection for C. trachomatis
Culture of C. trachomatis
http://ecampus.maseno.ac.ke Slide 16 of 5
Management
Antibiotics
◦ Tetracycline- oxytetracycline, doxycycline
◦ Erythromycin
http://ecampus.maseno.ac.ke Slide 17 of 5
Cystitis/Prostitis
Inflammation of the prostate
Etiology
◦ E.coli
◦ Proteus
◦ Klebsiela
http://ecampus.maseno.ac.ke Slide 18 of 5
Clinical presentation
Dysuria
Frequent micturation
Lower abdominal pains
Perineal pains
http://ecampus.maseno.ac.ke Slide 19 of 5
Investigations
Urine culture
Urethral discharge
http://ecampus.maseno.ac.ke Slide 20 of 5
Management
Antibiotics
◦ Quinolones
◦ Erythromycin
http://ecampus.maseno.ac.ke Slide 21 of 5
Asymptomatic Bacteriuria
Defined as more than 10 5 /ml organisms in the
mid stream urine of apparently health
asymptomatic patients.
1% of children under 1 yr of age
1% of school girls
0.03% of school boys and men
3% of adult non pregnant women
5% of pregnant women
http://ecampus.maseno.ac.ke Slide 22 of 5
Pyelonephritis
Inflammation of the kidney parenchyma and
the renal pelvis
May be:
◦ Acute pylonephritis
◦ Chronic pylonephritis
http://ecampus.maseno.ac.ke Slide 23 of 5
Pathogenesis of acute pyelonephritis
Etiology:
75% is caused E.coli
25% is caused by
◦ Protues
◦ Klebsiela
◦ Staphylococci
◦ Streptococci
Pyelonephritis usually follows ascending infection and a few
cases are blood borne.
Causes Inflammation of the renal pelvis
http://ecampus.maseno.ac.ke Slide 24 of 5
Clinical presentation
Abdominal pain
Dysuria
Strangury
Frequent micturation
Tendernesss on the lumber region
http://ecampus.maseno.ac.ke Slide 25 of 5
Investigations
Urine microscopy
Urine culture
Full haemogram
U/E/C
IVU
Abdominal ultrasound
http://ecampus.maseno.ac.ke Slide 26 of 5
Management
Antibiotics
◦ Quinolones
◦ Cephalosporins
◦ Penicilins
http://ecampus.maseno.ac.ke Slide 27 of 5
Chronic pyelonephritis
Chronic inflammation of the kidney
parenchyma.
Predisposing factor:
oVesico-ureteric reflux (VUR) in early life
http://ecampus.maseno.ac.ke Slide 28 of 5
Clinical presentation
In many cases no symptoms arise directly from
the renal disease
Vague ill-health
Symptoms of uraemia
Hypertension
http://ecampus.maseno.ac.ke Slide 29 of 5
Investigations
Urine culture
Full haemogram
U/E/C
Micturating cystourethragram (MCU)
http://ecampus.maseno.ac.ke Slide 30 of 5
Management
Chronic infection is difficult to eradicate
Attempt should be made to correct
abnormalities of the urinary tract
Antibiotics sensitive to the organism isolated
given for at least 7 days.
Treat hypertension
http://ecampus.maseno.ac.ke Slide 31 of 5
Renal tuberculosis
Etiology
◦ M.tuberculosis.
Occurs as secondary infection through
haematogenous spread
http://ecampus.maseno.ac.ke Slide 32 of 5
Pathogenesis
Initial lesion develops in the renal cortex,
if untreated may involve the renal pelvis then
the bladder, epididymis, seminal vesicles and
then the prostate
http://ecampus.maseno.ac.ke Slide 33 of 5
Clinical presentation
Malaise
Fever
Weight loss
Haematuria
Dysuria
http://ecampus.maseno.ac.ke Slide 34 of 5
Investigations
Urine microscopy
Urine culture
Full blood count.
U/E/C
IVU
Abdominal ultrasound
http://ecampus.maseno.ac.ke Slide 35 of 5
Management
Antituberculosis drugs
◦ INH
◦ Rifampicin
◦ Pyrazinamide
◦ Ethambutol
http://ecampus.maseno.ac.ke Slide 36 of 5
http://ecampus.maseno.ac.ke Slide 37 of 5